Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects |
| |
Authors: | Creagh T Ruckle J L Tolbert D T Giltner J Eiznhamer D A Dutta B Flavin M T Xu Z Q |
| |
Affiliation: | Clinical and Epidemiology Consultants, Atlanta, Georgia 30328, USA. |
| |
Abstract: | ![]()
|
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|